ES507995A0 - Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina. - Google Patents

Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina.

Info

Publication number
ES507995A0
ES507995A0 ES507995A ES507995A ES507995A0 ES 507995 A0 ES507995 A0 ES 507995A0 ES 507995 A ES507995 A ES 507995A ES 507995 A ES507995 A ES 507995A ES 507995 A0 ES507995 A0 ES 507995A0
Authority
ES
Spain
Prior art keywords
carboxy
chem
alkyl
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507995A
Other languages
English (en)
Other versions
ES8207539A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES507995A0 publication Critical patent/ES507995A0/es
Publication of ES8207539A1 publication Critical patent/ES8207539A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES507995A 1979-12-03 1981-12-15 Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina. Expired ES8207539A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7941607 1979-12-03
GB8031965 1980-10-03

Publications (2)

Publication Number Publication Date
ES507995A0 true ES507995A0 (es) 1982-10-01
ES8207539A1 ES8207539A1 (es) 1982-10-01

Family

ID=26273769

Family Applications (4)

Application Number Title Priority Date Filing Date
ES497426A Granted ES497426A0 (es) 1979-12-03 1980-12-03 Un procedimiento para preparar un compuesto de quinazolina
ES507994A Granted ES507994A0 (es) 1979-12-03 1981-12-15 Un procedimiento para la preparacion de un compuesto de quinazolina.
ES507995A Expired ES8207539A1 (es) 1979-12-03 1981-12-15 Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina.
ES507996A Expired ES8207540A1 (es) 1979-12-03 1981-12-15 Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES497426A Granted ES497426A0 (es) 1979-12-03 1980-12-03 Un procedimiento para preparar un compuesto de quinazolina
ES507994A Granted ES507994A0 (es) 1979-12-03 1981-12-15 Un procedimiento para la preparacion de un compuesto de quinazolina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES507996A Expired ES8207540A1 (es) 1979-12-03 1981-12-15 Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina.

Country Status (10)

Country Link
US (2) US4377580A (es)
EP (1) EP0030156B1 (es)
JP (1) JPH0651686B2 (es)
AT (1) ATE6778T1 (es)
AU (1) AU541811B2 (es)
DE (1) DE3067201D1 (es)
DK (1) DK513980A (es)
ES (4) ES497426A0 (es)
GR (1) GR71637B (es)
IE (1) IE51802B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046366A1 (de) * 1980-12-09 1982-07-08 Bayer Ag, 5090 Leverkusen Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung
JPS608274A (ja) * 1983-06-27 1985-01-17 Fujisawa Pharmaceut Co Ltd 新規キナゾリノン誘導体およびその製造法・並びに抗アレルギ−剤
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
US5420133A (en) * 1993-03-19 1995-05-30 Merck & Co., Inc. Quinazolinones substituted with phenoxyphenylacetic acid derivatives
WO2006076575A2 (en) 2005-01-13 2006-07-20 Bristol-Myers Squibb Company Substituted biaryl compounds as factor xia inhibitors
US8633186B2 (en) * 2007-06-08 2014-01-21 Senomyx Inc. Modulation of chemosensory receptors and ligands associated therewith
US9603848B2 (en) * 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
AU2013202912B2 (en) * 2007-06-08 2016-10-27 Firmenich Incorporated Modulation of chemosensory receptors and ligands associated therewith
US7928111B2 (en) * 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
EP2328426B1 (en) 2008-07-31 2014-10-01 Senomyx, Inc. Compositions comrpising sweetness enhancers and methods of making them
ES2647947T3 (es) 2008-07-31 2017-12-27 Senomyx, Inc. Procesos y productos intermedios para la preparación de potenciadores del sabor dulce
CN106107406B (zh) 2010-08-12 2020-06-09 弗门尼舍公司 提高甜味增强剂的稳定性的方法和包含稳定的甜味增强剂的组合物
EP2855459B1 (en) 2012-05-31 2020-04-29 F.Hoffmann-La Roche Ag Aminoquinazoline and pyridopyrimidine derivatives
EP3593648B1 (en) 2012-08-06 2021-07-14 Firmenich Incorporated Sweet flavor modifier
JO3155B1 (ar) 2013-02-19 2017-09-20 Senomyx Inc معدِّل نكهة حلوة
MX2021001193A (es) 2018-08-07 2021-04-28 Firmenich Incorporated 2,2-dioxidos de 4-amino-1h-benzo[c][1,2,6]tiadiazina 5-sustituidos y formulaciones y usos de los mismos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1086666A (en) * 1966-09-12 1967-10-11 Wander Ag Dr A Novel 6-p-tolyl-2,3,6,7-tetrahydro-4h-pyrimido-[1,2-c] quinazoline
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
BE759842R (fr) 1969-12-05 1971-06-03 Sandoz Sa Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces
CA986932A (en) * 1970-08-27 1976-04-06 Shigeho Inaba Process for preparing quinazoline derivatives
US4167569A (en) * 1976-12-09 1979-09-11 Imperial Chemical Industries Limited Pyrimido[1,2-a ]benzimidazole derivatives
US4105766A (en) * 1977-08-19 1978-08-08 Sterling Drug Inc. 4,5-Dihydro-5-oxopyrazolo[1,5-a]quinazoline-3-carboxylic acid derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents

Also Published As

Publication number Publication date
GR71637B (es) 1983-06-20
ES8205202A1 (es) 1982-06-01
ES8207539A1 (es) 1982-10-01
DE3067201D1 (en) 1984-04-26
US4377580A (en) 1983-03-22
DK513980A (da) 1981-06-04
EP0030156B1 (en) 1984-03-21
ES8301234A1 (es) 1982-11-16
EP0030156A1 (en) 1981-06-10
AU541811B2 (en) 1985-01-24
IE802421L (en) 1981-06-03
ES497426A0 (es) 1982-06-01
JPH0651686B2 (ja) 1994-07-06
ES507996A0 (es) 1982-10-01
ES507994A0 (es) 1982-11-16
AU6473380A (en) 1981-06-11
IE51802B1 (en) 1987-04-01
US4543356A (en) 1985-09-24
ATE6778T1 (de) 1984-04-15
JPH05294946A (ja) 1993-11-09
ES8207540A1 (es) 1982-10-01

Similar Documents

Publication Publication Date Title
ES507996A0 (es) Un procedimiento para la preparacion de un compuesto de pirimidoquinazolina.
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
DK165244C (da) Analogifremgangsmaade til fremstilling af 1,2,3-trisubstituerede indoler
ES549629A0 (es) Un procedimiento para preparar derivados de dihidropiridazi-nona
ES525653A0 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
ES519650A0 (es) Un procedimiento para obtener derivados de indanilbenzamida.
ES545728A0 (es) Procedimiento para preparar 5h,11h-pirrolo (2,1c)-(1,4)ben- zoxazepinas sustituidas en posicion 11
ES8504718A1 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES2056194T3 (es) Compuestos tetraciclicos antidepresivos.
ES515872A0 (es) "procedimiento para la preparacion de nuevos derivados de acidos 4-fenoxialcarboxilicos sustituidos con radicales haterociclicos".
ES554635A0 (es) Un procedimiento para preparar derivados de vinilisoquinolina
ES528816A0 (es) Procedimiento de producir compuestos para el tratamiento de la hipertension
ES554830A0 (es) Procedimiento para preparar derivados de 1,3-oxatiano
ES550817A0 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
ES548497A0 (es) Procedimiento para preparar compuestos de 3-amino-2,3-dihi- dro-1-benzoxepina
ES545870A0 (es) Procedimiento para preparar derivados de pirrolidindiona.